The short version
- An anaesthetist used AI to identify a rare vitamin B6 deficiency as the cause of life-threatening seizures in his mother, who has Parkinson’s disease.
- Immediate administration of intravenous vitamin B6 stopped the seizures, leading to a significant recovery in cognitive function and quality of life.
- Medical experts warn that while this case offers hope, clinical trials are necessary before changing standard care, and patients should not adjust medications independently.
A dramatic medical intervention involving artificial intelligence has brought renewed attention to the management of Parkinson’s disease complications. Ed Patrick, an anaesthetist from Oxfordshire, utilized AI tools to analyze recent medical literature after his mother, Ann, suffered continuous, life-threatening seizures that standard treatments failed to halt. The case highlights both the potential for technology to aid in complex diagnostic scenarios and the urgent need for further research into rare side effects of common Parkinson’s medications.
Ann Patrick had been deteriorating over several months before being admitted to a hospital in Nottinghamshire with non-stop convulsions. Medical staff informed her son that she was close to death, having exhausted standard anti-seizure medications. Upon arrival, Patrick found his mother unconscious and suffering from kidney failure alongside the relentless seizure activity. Facing a dire prognosis, he turned to Google’s Gemini AI tool to summarize recent medical journal articles relevant to her specific condition and symptoms.
The analysis pointed to a rare side effect linked to long-term use of carbidopa-levodopa, a standard combination drug used to boost dopamine levels in Parkinson’s patients. Patrick identified that the seizures were likely caused by a deficiency in vitamin B6. He relayed this finding to Dr. Bruno Gran, a consultant neurologist at Nottingham University Hospitals. Despite the unconventional origin of the diagnosis, the medical team agreed to administer an intravenous supplement of vitamin B6.
The response was immediate and profound. Within minutes of receiving the vitamin supplement, Ann’s seizure activity ceased entirely. She has not experienced another seizure since the intervention. Patrick reported that his mother has made a full recovery from the acute crisis and that her day-to-day cognitive symptoms have improved dramatically. He described her mental state as sharp, noting that it feels as though she has regained five to ten years of cognitive function.
Dr. Gran acknowledged the soundness of Patrick’s clinical reasoning, given his background in anaesthesia and pharmacology. However, he emphasized that the speed and magnitude of the recovery were unexpected. The medical team is now working to raise awareness of this potential issue within their own practice. While Parkinson’s affects millions globally, only fourteen similar cases have ever been reported, making this a rare but significant occurrence.
The case has drawn attention from health authorities and patient advocacy groups. Earlier this year, the US Food and Drug Administration issued a memo recommending that certain Parkinson’s drugs carry warnings about potential links to vitamin B6 deficiency. In the UK, Parkinson’s UK welcomed the prospect of more research trials, stating that such insights could transform care for some patients. However, experts caution that existing clinical evidence on this link remains limited.
Medical professionals stress that this single case does not constitute a universal treatment protocol. Doctors warn against patients making changes to their medication regimens without direct medical advice. The majority of NHS staff in the UK are reportedly unaware of this specific link between Parkinson’s medication and vitamin B6 deficiency. Consequently, there is a push for broader clinical trials to understand the prevalence and impact of this deficiency.
Patrick believes the implications extend beyond emergency settings, potentially offering solutions for long-term cognitive deterioration in other patients. His mother’s medical team has already presented her case to colleagues, leading to changes in regional practice regarding where B6 supplementation might be appropriate. As researchers build on this anecdotal evidence, the focus remains on validating these findings through rigorous study to ensure safe and effective care for future patients.
The incident underscores a growing intersection between patient advocacy, digital tools, and clinical medicine. While AI assisted in identifying a potential cause, it was the collaboration between family insight and medical expertise that led to the successful intervention. The coming months will likely see increased scrutiny of vitamin levels in Parkinson’s patients, aiming to prevent similar crises before they become life-threatening.
Sources behind this briefing
Go to the original reporting
- BBC News↗Son who used AI to help save mum's life hopes case unlocks clues for other Parkinson's patients
